lovastatin has been researched along with Chronic Disease in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 8 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gui, FF; Huo, XL; Jin, L; Min, JJ; Pan, CY; Pan, LL; Wang, XT; Zhao, CC | 1 |
| Chattopadhyay, A; Ganguly, S; Paila, YD; Pucadyil, TJ; Shrivastava, S | 1 |
| Azor, MH; da Silva Duarte, AJ; de Brito, CA; dos Santos, JC; Futata, EA; Maruta, CW; Rivitti, EA; Sato, MN | 1 |
| Miroshnichenko, NG; Neverov, NI; Stavrovskaia, EV; Tareeva, IE | 1 |
| Tareeva, IE | 1 |
| Kazumi, T; Maeda, E; Matsushita, M; Morita, M; Murata, Y; Nagata, K; Naka, Y; Yoshino, G | 1 |
| Gorrie, MJ; MacGregor, MS; Rodger, RS | 1 |
| Angelin, B; Juliusson, G; Vitols, S | 1 |
| Kaysen, GA; Neverov, NI; Tareyeva, IE | 1 |
| Bill, M; Gaciong, Z; Gałazka, Z; Gradowska, L; Paczek, L; Wyzgał, J | 1 |
| Kruse, W; Schlierf, G; Weber, E | 1 |
| Iurenev, AP; Kiseleva, OA; Lediashova, GA; Pomerantsev, EV; Zhukova, IM | 1 |
5 trial(s) available for lovastatin and Chronic Disease
| Article | Year |
|---|---|
[New approaches to the treatment of nephritis].
Topics: Animals; Cells, Cultured; Chronic Disease; Cyclophosphamide; Glomerulonephritis; Humans; Lovastatin; Lupus Nephritis; Mice; Nephritis; Nephrosclerosis; Nephrotic Syndrome; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Time Factors | 1995 |
Simvastatin impairs mitogen-induced proliferation of malignant B-lymphocytes from humans--in vitro and in vivo studies.
Topics: Adult; Aged; B-Lymphocytes; Cell Division; Cholesterol; Chronic Disease; Disease Progression; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Leukemia, Lymphoid; Lipids; Lipoproteins, LDL; Lovastatin; Male; Middle Aged; Mitogens; Pravastatin; Simvastatin; Thymidine; Tumor Cells, Cultured | 1997 |
Effect of lipid-lowering therapy on the progression of renal disease in nondiabetic nephrotic patients.
Topics: Adolescent; Adult; Aged; Anticholesteremic Agents; Cholesterol; Chronic Disease; Creatinine; Diet, Fat-Restricted; Disease Progression; Female; Glomerulonephritis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Lipoproteins; Lovastatin; Male; Middle Aged; Proteinuria | 1997 |
Non-immune factors in chronic rejection. Is there a role for hypolipemic drugs?
Topics: Adult; Apolipoproteins B; Cardiovascular Diseases; Cholesterol; Chronic Disease; Female; Graft Rejection; Humans; Hypolipidemic Agents; Kidney; Kidney Transplantation; Lipoproteins; Lovastatin; Male; Middle Aged; Risk Factors | 1997 |
Monitoring compliance in clinical trials.
Topics: Anticholesteremic Agents; Chronic Disease; Clinical Trials as Topic; Humans; Hyperlipoproteinemia Type II; Lovastatin; Microcomputers; Patient Compliance; Simvastatin | 1990 |
7 other study(ies) available for lovastatin and Chronic Disease
| Article | Year |
|---|---|
Efficacy of lovastatin on learning and memory deficits caused by chronic intermittent hypoxia-hypercapnia: through regulation of NR2B-containing NMDA receptor-ERK pathway.
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Chronic Disease; Disease Models, Animal; Excitatory Amino Acid Antagonists; Gene Expression Regulation; GTPase-Activating Proteins; Hippocampus; Hypercapnia; Hypoxia; Learning Disabilities; Lovastatin; Male; MAP Kinase Signaling System; Maze Learning; Membrane Microdomains; Memory Disorders; Neuropeptides; Nootropic Agents; Piperidines; Pulmonary Disease, Chronic Obstructive; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Spatial Learning; Synaptosomes | 2014 |
Chronic cholesterol depletion using statin impairs the function and dynamics of human serotonin(1A) receptors.
Topics: Animals; Anxiety; CHO Cells; Cholesterol; Chronic Disease; Cricetinae; Cricetulus; Depression; GTP-Binding Proteins; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ligands; Lovastatin; Protein Binding; Receptor, Serotonin, 5-HT1A; Receptors, G-Protein-Coupled | 2010 |
Statin effects on regulatory and proinflammatory factors in chronic idiopathic urticaria.
Topics: Adaptive Immunity; Adult; Aged; Cell Cycle; Cell Proliferation; Chemokine CCL3; Chronic Disease; Female; Humans; Immunity, Innate; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interleukin-10; Interleukin-17; Interleukin-6; Leukocytes, Mononuclear; Lovastatin; Male; Middle Aged; Phytohemagglutinins; RNA, Messenger; Simvastatin; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; T-Lymphocytes; Th1 Cells; Th2 Cells; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; Urticaria; Young Adult | 2011 |
[Antihyperlipidemic actions in the treatment of nephropathies].
Topics: Adolescent; Adult; Aged; Chronic Disease; Combined Modality Therapy; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Kidney Diseases; Lovastatin; Male; Middle Aged; Remission Induction | 1995 |
Effect of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on triglyceride kinetics in chronically streptozotocin-diabetic rats.
Topics: Animals; Cholesterol; Chronic Disease; Diabetes Mellitus, Experimental; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kinetics; Lipids; Lovastatin; Male; Rats; Rats, Wistar; Reference Values; Simvastatin; Triglycerides | 1993 |
Acute on chronic renal failure induced by simvastatin.
Topics: Acute Disease; Cardiovascular Diseases; Chronic Disease; Humans; Lovastatin; Male; Middle Aged; Renal Insufficiency; Simvastatin | 1996 |
[The effectiveness of the hypolipemic preparation lovastatin in patients with ischemic heart disease and hyperlipoproteinemia].
Topics: Adult; Chronic Disease; Coronary Artery Disease; Coronary Disease; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Hyperlipoproteinemias; Lipids; Lipoproteins; Lovastatin; Male; Middle Aged | 1989 |